We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00729092
Recruitment Status : Completed
First Posted : August 7, 2008
Last Update Posted : April 28, 2016
Information provided by (Responsible Party):

Study Description
Brief Summary:

Specific Aims:

• The primary objective is to delineate the brain structures that are involved in pain using Positron Emission Tomography (PET) imaging.


Pain will result in increases in metabolism and neuronal activity in specific delineated areas of the brain.

Condition or disease

  Show Detailed Description

Study Design

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Additional (Positron Emission Tomography)PET Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain
Study Start Date : May 2008
Primary Completion Date : November 2013
Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Nuclear Scans
U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :
  1. Pain Assessment Pain scores using the verbal rating scale, with 0 corresponding to "no pain" and 10 to the "worst imaginable pain" will be assessed prior to the primary PET scan [ Time Frame: 20 mins ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Between 18-80 years of age

Inclusion Criteria:1.

  • Subject who can understand and communicate in English

Exclusion Criteria:

  • Younger than 18 years or older than 80 years.
  • Greater than 90 kg body weight.
  • American Society of Anesthesiologists physical status IV.
  • Patient who is currently enrolled in another investigational study.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00729092

United States, Illinois
Rush University Medical Center
Chicago, Illinois, United States, 606012
Sponsors and Collaborators
Asokumar Buvanendran
Principal Investigator: Asokumar Buvanendran, MD Rush University Medical Center
More Information

Responsible Party: Asokumar Buvanendran, Attending Physician, Rush University Medical Center
ClinicalTrials.gov Identifier: NCT00729092     History of Changes
Other Study ID Numbers: 08042105
First Posted: August 7, 2008    Key Record Dates
Last Update Posted: April 28, 2016
Last Verified: April 2016

Keywords provided by Asokumar Buvanendran, Rush University Medical Center: